Heat Biologics

-$0.25 (-4.46%) As of 4:27 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Heat Biologics and other ETFs, options, and stocks.

About HTBX

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.

CEO
Jeff A. Wolf
Employees
39
Headquarters
Morrisville, North Carolina
Founded
2008

HTBX Key Statistics

Market Cap
135.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
165.06K
High Today
$5.56
Low Today
$5.24
Open Price
$5.56
Volume
398.26K
52 Week High
$17.00
52 Week Low
$5.22

HTBX Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure